A Study of Durvalumab (MEDI4736) in Esophageal Cancer
Clinical trial NCT02639065 · COMPLETED
Trial details
- NCT number
- NCT02639065
- Sponsor
- Shadia Jalal, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-27
- Primary completion
- 2020-12-09
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.